Home>
US Stocks>
Immunoprecise Antibodies

Immunoprecise Antibodies share price today

(IPA)

Immunoprecise Antibodies share price is $0.4 & ₹33.99 as on 21 Dec 2024, 2.30 'hrs' IST

$0.4

▲

-0.02

(-4.76%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Immunoprecise Antibodies share price in Dollar and Rupees. Guide to invest in Immunoprecise Antibodies from India. Also see the sentimental analysis on Indian investors investing in Immunoprecise Antibodies. Get details on the Indian mutual funds that are investing in Immunoprecise Antibodies. Get Analyst recommendations and forecasts along with all the Immunoprecise Antibodies's financials.

Immunoprecise Antibodies share price movements

Today's Low: $0.40
Today's High: $0.43
$0.40
0.3%
Downside
Day's Volatility :7.36%
Upside
7.08%
52 Weeks Low: $0.32
52 Weeks High: $2.60
$0.40
18.8%
Downside
52 Weeks Volatility :87.51%
Upside
84.62%

Immunoprecise Antibodies Returns

Period	Immunoprecise Antibodies Ltd	Index (Russel 2000)
3 Months	-37.73%	0.0%
6 Months	-59.61%	0.0%
1 Year	-70.14%	0.0%
3 Years	-92.54%	-19.7%

Immunoprecise Antibodies Key Statistics

in dollars & INR

Previous Close	$0.4201
Open	$0.4175
Today's High	$0.4305
Today's Low	$0.3988
Market Capitalization	$13.0M
Today's Volume	$192.8K
52 Week High	$2.6
52 Week Low	$0.3248
Revenue TTM	$24.1M
EBITDA	$-11.5M
Earnings Per Share (EPS)	$-0.75
Profit Margin	-115.22%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-64.04%

How to invest in Immunoprecise Antibodies from India?

It is very easy for Indian residents to invest directly in Immunoprecise Antibodies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunoprecise Antibodies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunoprecise Antibodies or IPA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunoprecise Antibodies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunoprecise Antibodies shares which would translate to 2.124 fractional shares of Immunoprecise Antibodies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Immunoprecise Antibodies, in just a few clicks!

Returns in Immunoprecise Antibodies for Indian investors in Rupees

Investment Value

₹1,00,000

Immunoprecise Antibodies investment value today

Current value as on today

₹1,72,345

Returns

₹72,345

(+72.35%)

Returns from Immunoprecise Antibodies Stock

₹70,149 (false-70.15%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Immunoprecise Antibodies

-21%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Immunoprecise Antibodies on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -21% less investors are searching Immunoprecise Antibodies in the last 30 days versus the previous period.

Global Institutional Holdings in Immunoprecise Antibodies

Ingalls & Snyder LLC
5.41%
Renaissance Technologies Corp
0.21%
BMO Capital Markets Corp.
0.20%
Bank of Montreal
0.20%
Northern Trust Corp
0.18%
CIBC World Markets Inc.
0.14%

Analyst Recommendation on Immunoprecise Antibodies

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Immunoprecise Antibodies(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Immunoprecise Antibodies

What analysts predicted

Upside of 1150.0%

Current:

$0.40

Target:

$5.00

Insights on Immunoprecise Antibodies

Price Movement
In the last 1 month, IPA stock has moved up by 14.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 5.26M → 6.12M (in $), with an average increase of 14.1% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -18.04M → -2.55M (in $), with an average increase of 203.9% per quarter
IPA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 104.5%
IPA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 116.0%
Price to Sales
ForIPA every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Immunoprecise Antibodies Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$8.2M	↑ 100.8%
Net Income	$-5.7M	↑ 47.31%
Net Profit Margin	-69.72%	↑ 25.31%

	FY20	Y/Y Change
Revenue	$10.0M	↑ 28.66%
Net Income	$-3.5M	↓ 35.05%
Net Profit Margin	-35.19%	↑ 34.53%

	FY21	Y/Y Change
Revenue	$14.3M	↑ 27.42%
Net Income	$-5.9M	↑ 48.36%
Net Profit Margin	-40.98%	↓ 5.79%

	FY22	Y/Y Change
Revenue	$15.3M	↑ 8.11%
Net Income	$-13.2M	↑ 127.64%
Net Profit Margin	-86.29%	↓ 45.31%

	FY23	Y/Y Change
Revenue	$15.3M	↑ 6.72%
Net Income	$-19.7M	↑ 58.96%
Net Profit Margin	-128.53%	↓ 42.24%

	FY24	Y/Y Change
Revenue	$17.9M	↑ 18.65%
Net Income	$-19.9M	↑ 2.32%
Net Profit Margin	-110.85%	↑ 17.68%

	Q3 FY23	Q/Q Change
Revenue	$3.5M	↓ 16.58%
Net Income	$-7.1M	↑ 82.9%
Net Profit Margin	-200.06%	↓ 108.81%

	Q4 FY23	Q/Q Change
Revenue	$4.5M	↑ 31.16%
Net Income	$-1.9M	↓ 72.05%
Net Profit Margin	-42.63%	↑ 157.43%

	Q1 FY24	Q/Q Change
Revenue	$4.6M	↑ 0.0%
Net Income	$-2.0M	↑ 0.0%
Net Profit Margin	-42.63%	↑ 0.0%

	Q2 FY24	Q/Q Change
Revenue	$4.7M	↑ 5.02%
Net Income	$-13.2M	↑ 588.22%
Net Profit Margin	-279.38%	↓ 236.75%

	Q3 FY24	Q/Q Change
Revenue	$3.8M	↓ 18.52%
Net Income	$-2.9M	↓ 77.84%
Net Profit Margin	-75.98%	↑ 203.4%

	Q4 FY24	Q/Q Change
Revenue	$6.1M	↑ 16.38%
Net Income	$-2.6M	↓ 36.16%
Net Profit Margin	-41.68%	↑ 34.3%

	FY19	Y/Y Change
Profit	$4.0M	↑ 116.02%

	FY20	Y/Y Change
Profit	$5.7M	↑ 51.74%

	FY21	Y/Y Change
Profit	$9.2M	↑ 43.61%

	FY22	Y/Y Change
Profit	$8.7M	↓ 4.81%

	FY23	Y/Y Change
Profit	$8.6M	↑ 5.28%

	FY24	Y/Y Change
Profit	$8.8M	↑ 4.24%

	Q3 FY23	Q/Q Change
Profit	$1.9M	↓ 25.8%

	Q4 FY23	Q/Q Change
Profit	$2.2M	↑ 19.16%

	Q1 FY24	Q/Q Change
Profit	$2.2M	↑ 0.0%

	Q2 FY24	Q/Q Change
Profit	$2.3M	↑ 5.21%

	Q3 FY24	Q/Q Change
Profit	$1.7M	↓ 24.2%

	Q4 FY24	Q/Q Change
Profit	$3.4M	↑ 45.88%

	FY19	Y/Y Change
Operating Cash Flow	$-2.4M	↓ 6.14%
Investing Cash Flow	$-1.6M	↓ 69.3%
Financing Cash Flow	$7.0M	↓ 4.59%

	FY20	Y/Y Change
Operating Cash Flow	$-990.1K	↓ 56.61%
Investing Cash Flow	$-1.1M	↓ 28.1%
Financing Cash Flow	$124.3K	↓ 98.13%

	FY21	Y/Y Change
Operating Cash Flow	$-480.0K	↓ 56.87%
Investing Cash Flow	$-2.0M	↑ 55.14%
Financing Cash Flow	$34.7M	↑ 24730.42%

	FY22	Y/Y Change
Operating Cash Flow	$-7.9M	↑ 1553.5%
Investing Cash Flow	$-4.1M	↑ 112.05%
Financing Cash Flow	$2.3M	↓ 93.35%

	FY23	Y/Y Change
Operating Cash Flow	$-14.7M	↑ 99.91%
Investing Cash Flow	$-1.5M	↓ 62.23%
Financing Cash Flow	$-460.7K	↓ 121.54%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-7.8M	↑ 361.68%
Investing Cash Flow	$-149.0K	↓ 55.63%
Financing Cash Flow	$-115.0K	↓ 60.1%

Immunoprecise Antibodies Technicals Summary

Sell

Neutral

Buy

Immunoprecise Antibodies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Immunoprecise Antibodies Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Immunoprecise Antibodies Ltd	6.41%	-59.61%	-70.14%	-92.54%	-97.5%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.38%	12.23%	86.41%
Biontech Se	4.48%	30.56%	7.97%	-55.71%	237.85%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.37%	26.29%	108.55%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-2.55%	77.79%	80.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Immunoprecise Antibodies Ltd	NA	NA	NA	-0.34	-0.64	-0.13	NA	1.26
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Immunoprecise Antibodies Ltd	Buy	$13.0M	-97.5%	NA	-115.22%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	86.41%	17.51	33.61%
Biontech Se	Buy	$26.7B	237.85%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.55%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.12%	32.84	-4.51%

About Immunoprecise Antibodies

immunoprecise antibodies is a highly specialized customer focused life sciences company that provides custom antibody development and immunology services from its headquarters in beautiful victoria, bc, canada. our dedication to advancing antibody development has resulted in cutting-edge immunological innovations such as single-step cloning, rapid prime immunization strategies, and recombinant monoclonal technology. we pride ourselves on our high customer satisfaction and our clients have grown accustomed to receiving thorough and professional service. we customize your project to generate antibodies that meet your specific needs. over our 20+ year history, we have gained the trust of a diverse group of customers that include research agencies, universities, biotechnology and pharmaceutical companies of all sizes from around the globe. immunoprecise is pleased to announce its newest line of services, immunoprotect™. with immunoprotect™, the dna sequence of your mab is determined and ca

Organization	Immunoprecise Antibodies
Employees	72
CEO	Dr. Jennifer Lynne Bath Ph.D.
Industry	Miscellaneous

Management People of Immunoprecise Antibodies

Name	Title
Dr. Jennifer Lynne Bath Ph.D.	CEO, President & Non-Independent Director
Ms. Kristin Taylor CPA, M.B.A.	Chief Financial Officer
Dr. Ilse Roodink	Chief Scientific Officer & Interim General Manager of IPA Europe, Oss
Ms. Kari Graber	Vice President of Commercial Services
Dr. Roland Romijn	Head of General Operations of the Utrecht site of IPA (Europe)

Important FAQs about investing in Immunoprecise Antibodies from India :

What is Immunoprecise Antibodies share price today?

Immunoprecise Antibodies share price today stands at $0.40, Open: $0.42 ; Previous Close: $0.42 ; High: $0.43 ; Low: $0.40 ; 52 Week High: $2.60 ; 52 Week Low: $0.32. The stock opens at $0.42, after a previous close of $0.42. The stock reached a daily high of $0.43 and a low of $0.40, with a 52-week high of $2.60 and a 52-week low of $0.32.

Can Indians buy Immunoprecise Antibodies shares?

Yes, Indians can invest in the Immunoprecise Antibodies (IPA) from India.

With INDmoney, you can buy Immunoprecise Antibodies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Immunoprecise Antibodies at zero transaction cost.

How can I buy Immunoprecise Antibodies shares from India?

It is very easy to buy Immunoprecise Antibodies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunoprecise Antibodies be purchased?

Yes, you can buy fractional shares of Immunoprecise Antibodies with INDmoney app.

What are the documents required to start investing in Immunoprecise Antibodies stocks?

To start investing in Immunoprecise Antibodies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.